An insightful conversation with Hryhorii Dunas, Director of the Halychyna Rehabilitation Center. Every day we see photos and videos from the front lines—feedback from our Defenders. But few people know what a patient’s life is like after an injury. Who is by their side, what hopes do they have, and what do they need? Let’s visit an institution...
READ MOREDeloitte’s external survey explores the drivers and impact of prolonged, unmanageable stress that may lead to employee burnout. Professionals today are undoubtedly feeling the pressure of an ‘always on’ work culture, causing stress and sometimes leading to burnout. Deloitte’s external marketplace survey of 1,000 full-time US professionals...
READ MOREGovernance in healthcare is not just about rules and regulations. It’s about creating a framework that ensures patient safety and quality care. As an integral part of healthcare management, good governance shapes the policies and procedures that maintain high standards in medical practices. In this article, we'll explore the vital role...
READ MOREKeith Carlson Keith Carlson, BSN, RN, NC-BC has been a nurse since 1996. As a holistic career coach, nurse podcaster, writer, blogger, and well-known motivational speaker, Keith empowers nurses regarding personal branding; professional networking; entrepreneurship; resume, job search, and interview strategies; emotional and relational intelligence;...
READ MOREAUTHORS Morenike Ayo-Vaughan Program Officer, Advancing Health Equity, The Commonwealth Fund Laurie C. Zephyrin Senior Vice President, Advancing Health Equity, The Commonwealth Fund A recent survey of 3,000 health care workers revealed that younger clinicians ages 18–29 — nurses, doctors, dentists,...
READ MOREThe term “safety” in the context of biopharmaceutical manufacturing is ambiguous: On the one side, it refers to the safe applicability of pharmaceutical products in clinical settings. The products not only have to be effective, but the risks for patients upon administration need to be predictable as well, which is why tolerability is...
READ MOREThe transition from clinical to commercial manufacturing is a critical juncture in the lifecycle of biological medicines. It embodies the complex interplay between biotechnological innovation, regulatory rigour, and commercial strategy. Successfully navigating this phase is pivotal for delivering breakthrough therapies to patients worldwide,...
READ MORE"Check against delivery" Ladies and gentlemen, friends and colleagues, Thank you for the opportunity to speak today and to hear the different voices and views on this new and very important Report from the Lancet Breast Cancer Commission. My congratulations to all those involved in its research and findings. Cancer affects...
READ MOREImagine yourself as a skilled tightrope walker gracefully navigating a crowded hospital atrium. Below you, a sea of patients and staff represents the sensitive patient health information (PHI) you manage daily. Your goal? Confidentiality must be ensured to traverse this digital tightrope securely while clear communication is maintained. This,...
READ MORE